glutathione and pulmonary hypertension Pathophysiology of Group 3 Associated with Lung Diseases and/or Hypoxia Immunotherapy of Endothelin-1 Receptor Type
Immunotherapy of Endothelin 1 Receptor Type A for Pulmonary Arterial Hypertension JACC Frontiers Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies AduAmankwaah 2025 MedComm Wiley Online Library Frontiers Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening Molecular Pathways in Pulmonary Arterial Hypertension
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




